|
1
|
Gacche RN and Meshram RJ: Targeting tumor
micro-environment for design and development of novel
anti-angiogenic agents arresting tumor growth. Prog Biophys Mol
Biol. 113:333–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stuehr DJ: Mammalian nitric oxide
synthases. Biochim Biophys Acta. 1411:217–230. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marinos RS, Zhang W, Wu G, Kelly KA and
Meininger CJ: Tetrahydrobiopterin levels regulate endothelial cell
proliferation. Am J Physiol Heart Circ Physiol. 281:H482–H489.
2001.PubMed/NCBI
|
|
4
|
Ridnour LA, Isenberg JS, Espey MG, Thomas
DD, Roberts DD and Wink DA: Nitric oxide regulates angiogenesis
through a functional switch involving thrombospondin-1. Proc Natl
Acad Sci USA. 102:13147–13152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burke AJ, Sullivan FJ, Giles FJ and Glynn
SA: The yin and yang of nitric oxide in cancer progression.
Carcinogenesis. 34:503–512. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fukumura D, Kashiwagi S and Jain RK: The
role of nitric oxide in tumour progression. Nat Rev Cancer.
6:521–534. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ying L and Hofseth LJ: An emerging role
for endothelial nitric oxide synthase in chronic inflammation and
cancer. Cancer Res. 67:1407–1410. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barbieri A, Palma G, Rosati A, Giudice A,
Falco A, Petrillo A, Petrillo M, Bimonte S, Di Benedetto M,
Esposito G, et al: Role of endothelial nitric oxide synthase (eNOS)
in chronic stress-promoted tumour growth. J Cell Mol Med.
16:920–926. 2012. View Article : Google Scholar
|
|
9
|
Jadeski LC and Lala PK: Nitric oxide
synthase inhibition by NG-nitro-L-arginine methyl ester
inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol.
155:1381–1390. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katusic ZS, d'Uscio LV and Nath KA:
Vascular protection by tetrahydrobiopterin: Progress and
therapeutic prospects. Trends Pharmacol Sci. 30:48–54. 2009.
View Article : Google Scholar :
|
|
11
|
Lowndes SA, Sheldon HV, Cai S, Taylor JM
and Harris AL: Copper chelator ATN-224 inhibits endothelial
function by multiple mechanisms. Microvasc Res. 77:314–326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thöny B, Auerbach G and Blau N:
Tetrahydrobiopterin biosynthesis, regeneration and functions.
Biochem J. 347:1–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Zeng X, Wang J, Briggs SS, O'Neill
E, Li J, Leek R, Kerr DJ, Harris AL and Cai S: Roles of
tetrahydrobiopterin in promoting tumor angiogenesis. Am J Pathol.
177:2671–2680. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sugiyama T, Levy BD and Michel T:
Tetrahydrobiopterin recycling, a key determinant of endothelial
nitric-oxide synthase-dependent signaling pathways in cultured
vascular endothelial cells. J Biol Chem. 284:12691–12700. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lampson BL, Kendall SD, Ancrile BB,
Morrison MM, Shealy MJ, Barrientos KS, Crowe MS, Kashatus DF, White
RR, Gurley SB, et al: Targeting eNOS in pancreatic cancer. Cancer
Res. 72:4472–4482. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alp NJ, Mussa S, Khoo J, Cai S, Guzik T,
Jefferson A, Goh N, Rockett KA and Channon KM:
Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated
endothelial function in diabetes by targeted transgenic
GTP-cyclohydrolase I overexpression. J Clin Invest. 112:725–735.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sampat KR and O'Neil B: Antiangiogenic
therapies for advanced hepatocellular carcinoma. Oncologist.
18:430–438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu AX, Duda DG, Sahani DV and Jain RK:
HCC and angiogenesis: Possible targets and future directions. Nat
Rev Clin Oncol. 8:292–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rodriguez-Viciana P and Downward J: Ras
activation of phosphatidylinositol 3-kinase and Akt. Methods
Enzymol. 333:37–44. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Engelman JA, Chen L, Tan X, Crosby K,
Guimaraes AR, Upadhyay R, Maira M, McNamara K, Perera SA, Song Y,
et al: Effective use of PI3K and MEK inhibitors to treat mutant
Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med.
14:1351–1356. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stoeltzing O, Meric-Bernstam F and Ellis
LM: Intracellular signaling in tumor and endothelial cells: The
expected and, yet again, the unexpected. Cancer Cell. 10:89–91.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah
G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I,
Nagy JA, et al: Pathological angiogenesis is induced by sustained
Akt signaling and inhibited by rapamycin. Cancer Cell. 10:159–170.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng H, Dai T, Zhou B, Zhu J, Huang H,
Wang M and Fu G: SDF-1alpha/CXCR4 decreases endothelial progenitor
cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway.
Atherosclerosis. 201:36–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Michaelis M, Michaelis R, Suhan T, Schmidt
H, Mohamed A, Doerr HW and Cinatl J Jr: Ribavirin inhibits
angiogenesis by tetrahydrobiopterin depletion. FASEB J. 21:81–87.
2007. View Article : Google Scholar
|
|
26
|
Dimmeler S, Fleming I, Fisslthaler B,
Hermann C, Busse R and Zeiher AM: Activation of nitric oxide
synthase in endothelial cells by Akt-dependent phosphorylation.
Nature. 399:601–605. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du YH, Guan YY, Alp NJ, Channon KM and
Chen AF: Endothelium-specific GTP cyclohydrolase I overexpression
attenuates blood pressure progression in salt-sensitive low-renin
hypertension. Circulation. 117:1045–1054. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ceylan-Isik AF, Guo KK, Carlson EC,
Privratsky JR, Liao SJ, Cai L, Chen AF and Ren J: Metallothionein
abrogates GTP cyclohydrolase I inhibition-induced cardiac
contractile and morphological defects: Role of mitochondrial
biogenesis. Hypertension. 53:1023–1031. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kolinsky MA and Gross SS: The mechanism of
potent GTP cyclohydrolase I inhibition by
2,4-diamino-6-hydroxypyrimidine: Requirement of the GTP
cyclohydrolase I feedback regulatory protein. J Biol Chem.
279:40677–40682. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie L, Smith JA and Gross SS: GTP
cyclohydrolase I inhibition by the prototypic inhibitor
2,4-diamino-6-hydroxypyrimidine. Mechanisms and unanticipated role
of GTP cyclohydrolase I feedback regulatory protein. J Biol Chem.
273:21091–21098. 1998. View Article : Google Scholar : PubMed/NCBI
|
